Amidst the "amyloid mafia" debate, Sarah Ackley chimes in with a concrete proposal that would very quickly deliver better evidence on how to treat Alzheimer's disease and the promise of anti-amyloid therapies: the companies should share the data for combined, individual-level analyses.
Reposted from
Sarah Ackley
Check out my letter on amyloid-targeting drugs in STAT!
www.statnews.com/2025/02/22/l...
A thread
#episky
www.statnews.com/2025/02/22/l...
A thread
#episky
Comments